Newsroom

Newsroom

A Novel Multimodal Next Generation Sequencing Assay with Total Nucleic Acid Input to Provide Comprehensive Genomic Profiling for Hematologic Malignancies

Literature
Read More

Accessing Genomic Alternations in Chronic Lymphocytic Leukemia Using an NGS-Based Comprehensive Genomic Profiling Assay

Literature
Read More

Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer

Literature
Read More

Oncology Clinical Trials During a Pandemic

Blog
Read More

Using multiplexed immunofluorescence to quantitatively analyze myeloid derived suppressor cells (MDSCs) in relation to tertiary lymphoid structures (TLS) in bladder cancer

Literature
Read More

Identification of lung cancer mutational signatures and tumor drivers associated with specific bimodal PD-L1/TMB status

Literature
Read More

It’s a Great Clinical Trial Assay

Blog
Read More

Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients